These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 36183086)
1. Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate. Andreasen CM; Klicman RF; Herlin T; Hauge EM; Jurik AG Pediatr Rheumatol Online J; 2022 Oct; 20(1):85. PubMed ID: 36183086 [TBL] [Abstract][Full Text] [Related]
2. Response to Early-onset Pamidronate Treatment in Chronic Nonbacterial Osteomyelitis: A Retrospective Single-center Study. Andreasen CM; Jurik AG; Glerup MB; Høst C; Mahler BT; Hauge EM; Herlin T J Rheumatol; 2019 Nov; 46(11):1515-1523. PubMed ID: 30988129 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. Roderick M; Shah R; Finn A; Ramanan AV Rheumatology (Oxford); 2014 Nov; 53(11):1973-6. PubMed ID: 24899664 [TBL] [Abstract][Full Text] [Related]
4. Whole-body MRI Quantification for Assessment of Bone Lesions in Chronic Nonbacterial Osteomyelitis Patients Treated With Pamidronate: A Prevalence, Reproducibility, and Responsiveness Study. Panwar J; Tolend M; Lim L; Tse SM; Doria AS; Laxer RM; Stimec J J Rheumatol; 2021 May; 48(5):751-759. PubMed ID: 32934131 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity. Bhat CS; Roderick M; Sen ES; Finn A; Ramanan AV Pediatr Rheumatol Online J; 2019 Jul; 17(1):35. PubMed ID: 31272461 [TBL] [Abstract][Full Text] [Related]
10. Preferential involvement of the pelvis and hips along with active sacroiliitis in chronic nonbacterial osteomyelitis: MRI of 97 patients from a single tertiary referral center. Aydıngöz Ü; Yıldız AE; Ayaz E; Batu ED; Özen S Eur Radiol; 2024 Aug; 34(8):4979-4987. PubMed ID: 38180529 [TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic recurrent multifocal osteomyelitis with bisphosphonates in children. Sułko J; Ebisz M; Bień S; Błażkiewicz M; Jurczyk M; Namyślak M Joint Bone Spine; 2019 Nov; 86(6):783-788. PubMed ID: 31216487 [TBL] [Abstract][Full Text] [Related]
12. Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children. Juszczak B; Sułko J Rheumatol Int; 2022 Apr; 42(4):699-706. PubMed ID: 34018012 [TBL] [Abstract][Full Text] [Related]
13. Chronic non-bacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) with a focus on pamidronate therapy. Bouchalova K; Pytelova Z Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Apr; ():. PubMed ID: 38682664 [TBL] [Abstract][Full Text] [Related]
14. Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis. Kostik MM; Kopchak OL; Chikova IA; Isupova EA; Mushkin AY Rheumatol Int; 2019 Jan; 39(1):89-96. PubMed ID: 30171342 [TBL] [Abstract][Full Text] [Related]
15. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate. Hofmann C; Wurm M; Schwarz T; Neubauer H; Beer M; Girschick H; Morbach H Clin Exp Rheumatol; 2014; 32(4):604-9. PubMed ID: 25065777 [TBL] [Abstract][Full Text] [Related]
16. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Hospach T; Langendoerfer M; von Kalle T; Maier J; Dannecker GE Eur J Pediatr; 2010 Sep; 169(9):1105-11. PubMed ID: 20339868 [TBL] [Abstract][Full Text] [Related]
17. Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. Ramanan AV; Hampson LV; Lythgoe H; Jones AP; Hardwick B; Hind H; Jacobs B; Vasileiou D; Wadsworth I; Ambrose N; Davidson J; Ferguson PJ; Herlin T; Kavirayani A; Killeen OG; Compeyrot-Lacassagne S; Laxer RM; Roderick M; Swart JF; Hedrich CM; Beresford MW PLoS One; 2019; 14(6):e0215739. PubMed ID: 31166977 [TBL] [Abstract][Full Text] [Related]